At this year's SupplySide Global event, Bioenergy Life Sciences (BLS) will launch its two next-gen, clinically studied ingredients, designed to redefine what’s possible in supplement innovation.
"Our scientists and R&D teams work ahead of the curve to develop ingredients that are innovative, clinically studied and do it better."
"Our branded ingredients and product solutions are ready to help you go beyond the ordinary,” says BLS Vice President of Sales Marianne McDonagh.
BLS will unveil the following:
- RQX: a category-first co-crystal of quercetin, nicotinamide (B3) and D-ribose that reduces inflammation, combats glycation and supports NAD+ levels
- Highly bioavailable and formulated for superior synergy and solubility
- PeakPwr: a stable, formulator-friendly combination of creatine monohydrate and D-ribose that improves cellular metabolism, energy, recovery and muscle performance
- Designed for flexible applications from gummies to RTDs.
"PeakPwr is an easy and logical way to differentiate your product."
"Creatine and D-ribose are quite simply better together."
"Creatine Monohydrate helps initiate ATP production, while D-Ribose provides the critical building blocks to keep it going, even during stress," explains McDonagh.
"It is suitable for tablets, capsules, RTDs, powdered stacks, gummies, bars, liquids and much more."
Attendees are also encouraged to visit the panel discussion, which will advise on using science and innovation to transform products into leaders
Dr Michael Crabtree, BLS’s Director of Scientific Affairs, will speak at "More than the formula: what R&D needs to succeed" on October 28, 3:30-5:30 pm, in Islander Ballroom E.